Stroke diagnosis and treatment informed by the latest scientific research and discovery.
Three centers focused on the full spectrum of stroke detection, technology design, treatment and recovery.
A multidisciplinary team leading a global effort to improve outcomes for stroke patients.
Created through a generous philanthropic gift from the United Arab Emirates (UAE), the Sheikh Khalifa Stroke Institute signals a new direction in the understanding of stroke and opens an era of renewed hope for patients, families and communities in the U.S. and UAE.
The institute, operating in Baltimore and the UAE, draws on Johns Hopkins’ vast leadership in stroke diagnosis, treatment and rehabilitation, including biomedical research; innovative technology design; acute medical and surgical treatment; brain repair and neuroplasticity; behavioral recovery; stroke systems of care; prevention and public health.
Learn more about other collaborations between Johns Hopkins and UAE and other locations in the Middle East, as well as our care for international patients through Johns Hopkins Medicine International.
Transforming Stroke Care Worldwide
By working with a unified purpose, Johns Hopkins and UAE scientists and practitioners can more efficiently translate science and technological innovations into treatments, reducing the toll of stroke in the UAE, the U.S. and the world.
Congratulations to Drs. Raghavan, Urrutia and Hillis!
SKSI recently celebrated the induction of three new titles:
- Dr. Preeti Raghavan was named the Sheikh Khalifa Stroke Institute Professor of Stroke Treatment, Recovery and Rehabilitation.
- Dr. Victor Urrutia was named the Sheikh Khalifa Stroke Institute Director.
- Dr. Argye Hillis was named the Sheikh Khalifa Stroke Institute Professor of Acute Stroke Diagnoses and Management